The results of the current study demonstrated that young age is a negative prognostic factor, particularly for HR+/HER2- breast cancer (hazard ratio, 1.55), which is consistent with the results of previous studies (Partridge et al., 2016; Fu et al., 2019). This evidence concerns the gene ERBB2 and breast cancer.